Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.41789176 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.41789176 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.16213301 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.16213301 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.72521772 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.10831595 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.10831595 |
8 | tryptophan catabolic process (GO:0006569) | 6.10831595 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05378733 |
10 | glyoxylate metabolic process (GO:0046487) | 5.93813209 |
11 | kynurenine metabolic process (GO:0070189) | 5.92142470 |
12 | urea cycle (GO:0000050) | 5.80288660 |
13 | urea metabolic process (GO:0019627) | 5.80288660 |
14 | bile acid biosynthetic process (GO:0006699) | 5.80042669 |
15 | tryptophan metabolic process (GO:0006568) | 5.75792767 |
16 | cysteine metabolic process (GO:0006534) | 5.71048384 |
17 | sulfur amino acid catabolic process (GO:0000098) | 5.48420639 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42188760 |
19 | nitrogen cycle metabolic process (GO:0071941) | 5.34908556 |
20 | serine family amino acid catabolic process (GO:0009071) | 5.33680935 |
21 | negative regulation of fibrinolysis (GO:0051918) | 5.31461139 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26540441 |
23 | epoxygenase P450 pathway (GO:0019373) | 5.11259378 |
24 | complement activation, alternative pathway (GO:0006957) | 5.10372225 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07593840 |
26 | protein carboxylation (GO:0018214) | 5.07593840 |
27 | regulation of fibrinolysis (GO:0051917) | 5.05572170 |
28 | regulation of protein activation cascade (GO:2000257) | 5.05198665 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04030895 |
30 | lysine metabolic process (GO:0006553) | 4.96129741 |
31 | lysine catabolic process (GO:0006554) | 4.96129741 |
32 | homocysteine metabolic process (GO:0050667) | 4.95949535 |
33 | bile acid metabolic process (GO:0008206) | 4.94086345 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 4.89829526 |
35 | glycine metabolic process (GO:0006544) | 4.79843960 |
36 | amino-acid betaine metabolic process (GO:0006577) | 4.79722157 |
37 | regulation of triglyceride catabolic process (GO:0010896) | 4.76898792 |
38 | regulation of complement activation (GO:0030449) | 4.71374875 |
39 | alpha-amino acid catabolic process (GO:1901606) | 4.69350037 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.63314817 |
41 | reverse cholesterol transport (GO:0043691) | 4.60495513 |
42 | tyrosine metabolic process (GO:0006570) | 4.59954330 |
43 | protein-lipid complex remodeling (GO:0034368) | 4.57381462 |
44 | macromolecular complex remodeling (GO:0034367) | 4.57381462 |
45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.57381462 |
46 | acylglycerol homeostasis (GO:0055090) | 4.47616993 |
47 | triglyceride homeostasis (GO:0070328) | 4.47616993 |
48 | * serine family amino acid metabolic process (GO:0009069) | 4.42194714 |
49 | negative regulation of cholesterol transport (GO:0032375) | 4.40866550 |
50 | negative regulation of sterol transport (GO:0032372) | 4.40866550 |
51 | imidazole-containing compound metabolic process (GO:0052803) | 4.40346674 |
52 | cellular amino acid catabolic process (GO:0009063) | 4.35710432 |
53 | phospholipid efflux (GO:0033700) | 4.34888267 |
54 | protein-lipid complex assembly (GO:0065005) | 4.33211212 |
55 | cellular ketone body metabolic process (GO:0046950) | 4.30946780 |
56 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.29337726 |
57 | indolalkylamine metabolic process (GO:0006586) | 4.29337089 |
58 | bile acid and bile salt transport (GO:0015721) | 4.25066012 |
59 | exogenous drug catabolic process (GO:0042738) | 4.24669107 |
60 | coenzyme catabolic process (GO:0009109) | 4.22998946 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 4.22588076 |
62 | cellular biogenic amine catabolic process (GO:0042402) | 4.19699549 |
63 | amine catabolic process (GO:0009310) | 4.19699549 |
64 | cellular modified amino acid catabolic process (GO:0042219) | 4.19555812 |
65 | glutamate metabolic process (GO:0006536) | 4.18634260 |
66 | cellular glucuronidation (GO:0052695) | 4.18292393 |
67 | * serine family amino acid biosynthetic process (GO:0009070) | 4.08693295 |
68 | ethanol oxidation (GO:0006069) | 4.08585993 |
69 | benzene-containing compound metabolic process (GO:0042537) | 4.06663954 |
70 | aldehyde catabolic process (GO:0046185) | 4.05443584 |
71 | drug catabolic process (GO:0042737) | 4.01043198 |
72 | NADH metabolic process (GO:0006734) | 3.99614340 |
73 | cholesterol efflux (GO:0033344) | 3.96257174 |
74 | arginine metabolic process (GO:0006525) | 3.93308100 |
75 | omega-hydroxylase P450 pathway (GO:0097267) | 3.91317689 |
76 | plasma lipoprotein particle assembly (GO:0034377) | 3.89608041 |
77 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.86879038 |
78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83160977 |
79 | carboxylic acid catabolic process (GO:0046395) | 3.81383587 |
80 | organic acid catabolic process (GO:0016054) | 3.81383587 |
81 | urate metabolic process (GO:0046415) | 3.75214748 |
82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74029567 |
83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74029567 |
84 | fibrinolysis (GO:0042730) | 3.72619314 |
85 | acetyl-CoA metabolic process (GO:0006084) | 3.71796247 |
86 | ketone body metabolic process (GO:1902224) | 3.71104586 |
87 | uronic acid metabolic process (GO:0006063) | 3.70426350 |
88 | glucuronate metabolic process (GO:0019585) | 3.70426350 |
89 | cholesterol homeostasis (GO:0042632) | 3.68949950 |
90 | cofactor catabolic process (GO:0051187) | 3.68898202 |
91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68713512 |
92 | phospholipid homeostasis (GO:0055091) | 3.67362843 |
93 | drug transmembrane transport (GO:0006855) | 3.66827692 |
94 | short-chain fatty acid metabolic process (GO:0046459) | 3.66353198 |
95 | response to nitrosative stress (GO:0051409) | 3.65273926 |
96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64705084 |
97 | aspartate family amino acid catabolic process (GO:0009068) | 3.64365045 |
98 | sterol homeostasis (GO:0055092) | 3.63648658 |
99 | proline metabolic process (GO:0006560) | 3.63586770 |
100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63390927 |
101 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.62012644 |
102 | regulation of cholesterol homeostasis (GO:2000188) | 3.60643752 |
103 | positive regulation of lipid catabolic process (GO:0050996) | 3.56825037 |
104 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56580711 |
105 | carnitine metabolic process (GO:0009437) | 3.56217907 |
106 | cytolysis (GO:0019835) | 3.54004178 |
107 | complement activation, classical pathway (GO:0006958) | 3.53954298 |
108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.52106287 |
109 | acute-phase response (GO:0006953) | 3.51404728 |
110 | plasma lipoprotein particle organization (GO:0071827) | 3.49725939 |
111 | fructose metabolic process (GO:0006000) | 3.45310149 |
112 | drug metabolic process (GO:0017144) | 3.44973733 |
113 | negative regulation of hemostasis (GO:1900047) | 3.40337881 |
114 | negative regulation of blood coagulation (GO:0030195) | 3.40337881 |
115 | proline biosynthetic process (GO:0006561) | 3.38856077 |
116 | intestinal absorption (GO:0050892) | 3.38708382 |
117 | protein-lipid complex subunit organization (GO:0071825) | 3.37500605 |
118 | angiotensin maturation (GO:0002003) | 3.36959145 |
119 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.36003211 |
120 | intestinal cholesterol absorption (GO:0030299) | 3.35596415 |
121 | glycosphingolipid catabolic process (GO:0046479) | 3.29075368 |
122 | regulation of plasminogen activation (GO:0010755) | 3.27522879 |
123 | oxaloacetate metabolic process (GO:0006107) | 3.27447696 |
124 | ethanol metabolic process (GO:0006067) | 3.26620809 |
125 | protein activation cascade (GO:0072376) | 3.21902845 |
126 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.13945890 |
127 | negative regulation of coagulation (GO:0050819) | 3.10468076 |
128 | complement activation (GO:0006956) | 3.10450815 |
129 | glycolipid catabolic process (GO:0019377) | 3.08930294 |
130 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.02527861 |
131 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.00174243 |
132 | oligosaccharide catabolic process (GO:0009313) | 2.95658349 |
133 | regulation of humoral immune response (GO:0002920) | 2.94975575 |
134 | polyketide metabolic process (GO:0030638) | 2.92920891 |
135 | doxorubicin metabolic process (GO:0044598) | 2.92920891 |
136 | daunorubicin metabolic process (GO:0044597) | 2.92920891 |
137 | negative regulation of wound healing (GO:0061045) | 2.89598681 |
138 | lipoprotein metabolic process (GO:0042157) | 2.85391772 |
139 | regulation of apoptotic cell clearance (GO:2000425) | 2.84598043 |
140 | COPI coating of Golgi vesicle (GO:0048205) | 2.82047929 |
141 | Golgi transport vesicle coating (GO:0048200) | 2.82047929 |
142 | hormone catabolic process (GO:0042447) | 2.78662343 |
143 | negative regulation of lipid transport (GO:0032369) | 2.77705217 |
144 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.75592097 |
145 | phenylpropanoid metabolic process (GO:0009698) | 2.75458329 |
146 | regulation of lipoprotein particle clearance (GO:0010984) | 2.73847748 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.13011821 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.06508003 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.80839012 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14620814 |
5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17750222 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.00298236 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.92967089 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.19976064 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.62445928 |
10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.27266900 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20942983 |
12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20525594 |
13 | MYC_22102868_ChIP-Seq_BL_Human | 2.16764745 |
14 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5813834 |
15 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99060265 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91880542 |
17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79966092 |
18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70271032 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55818771 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54690785 |
21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54331884 |
22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47966770 |
23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.46816820 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45350834 |
25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41840535 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40020189 |
27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37873094 |
28 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33613438 |
29 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32437224 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32184289 |
31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30376214 |
32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30302714 |
33 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.28591592 |
34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27737622 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26051944 |
36 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25631793 |
37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24668460 |
38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22617158 |
39 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22586296 |
40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21806663 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20056621 |
42 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19216144 |
43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17449003 |
44 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16940805 |
45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15502927 |
46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12381344 |
47 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11998761 |
48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10992457 |
49 | MAF_26560356_Chip-Seq_TH1_Human | 1.10314434 |
50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10081912 |
51 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09253358 |
52 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09240854 |
53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08994829 |
54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08842265 |
55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08136226 |
56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06229692 |
57 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04919704 |
58 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04270557 |
59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03644139 |
60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03265142 |
61 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02705226 |
62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02686552 |
63 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.01465890 |
64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01370899 |
65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00984190 |
66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00501537 |
67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99921863 |
68 | * P68_20966046_ChIP-Seq_HELA_Human | 0.99883901 |
69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98873452 |
70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.98281939 |
71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97878893 |
72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97848021 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97844738 |
74 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97786226 |
75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97690212 |
76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97305794 |
77 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97221526 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96022531 |
79 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95311186 |
80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95113312 |
81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93950253 |
82 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93904406 |
83 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93091140 |
84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93027544 |
85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91785474 |
86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91267967 |
87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91043272 |
88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90793756 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87457904 |
90 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86231919 |
91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85221658 |
92 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84698900 |
93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82547214 |
94 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.79397606 |
95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.78537489 |
96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.76136306 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75898261 |
98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72925449 |
99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71786887 |
100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70102595 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69822609 |
102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68742889 |
103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68193941 |
104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63690607 |
105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.63623843 |
106 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.63205577 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61454133 |
108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61425143 |
109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60170888 |
110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.58699241 |
111 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.58676761 |
112 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56747320 |
113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56191440 |
114 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55865625 |
115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55043076 |
116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.54107081 |
117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54095784 |
118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53704717 |
119 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52526874 |
120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52120714 |
121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50285502 |
122 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48495242 |
123 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.48487090 |
124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47594564 |
125 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46766619 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46549557 |
127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.45595089 |
128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44458490 |
129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44049739 |
130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43814994 |
131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43660376 |
132 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.43203930 |
133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.43161005 |
134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.43153311 |
135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.42986672 |
136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42874326 |
137 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.42484018 |
138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.42385848 |
139 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.42341044 |
140 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.42286981 |
141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.42022544 |
142 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.41361473 |
143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.41226817 |
144 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.41153610 |
145 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40931584 |
146 | P300_27268052_Chip-Seq_Bcells_Human | 0.39695887 |
147 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.39692495 |
148 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.39449003 |
149 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.39251044 |
150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.38675338 |
151 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.38609466 |
152 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.38365029 |
153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.38358983 |
154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.37367045 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.10027074 |
2 | MP0005360_urolithiasis | 7.59687227 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.18105684 |
4 | MP0005365_abnormal_bile_salt | 6.01169868 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87849383 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.49577598 |
7 | MP0003252_abnormal_bile_duct | 3.74946344 |
8 | MP0010329_abnormal_lipoprotein_level | 3.43514106 |
9 | MP0009840_abnormal_foam_cell | 3.25829774 |
10 | MP0005083_abnormal_biliary_tract | 2.98368423 |
11 | MP0005332_abnormal_amino_acid | 2.88817622 |
12 | MP0003195_calcinosis | 2.74542217 |
13 | MP0001666_abnormal_nutrient_absorption | 2.65353498 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.32262194 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.26296037 |
16 | MP0000609_abnormal_liver_physiology | 2.17979379 |
17 | MP0003303_peritoneal_inflammation | 2.06878697 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.01700253 |
19 | MP0002138_abnormal_hepatobiliary_system | 2.01205586 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.89010213 |
21 | MP0003868_abnormal_feces_composition | 1.82343875 |
22 | MP0001764_abnormal_homeostasis | 1.80068680 |
23 | MP0003172_abnormal_lysosome_physiology | 1.64516056 |
24 | MP0003186_abnormal_redox_activity | 1.55671280 |
25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55380583 |
26 | MP0003183_abnormal_peptide_metabolism | 1.50248005 |
27 | MP0005451_abnormal_body_composition | 1.46909008 |
28 | MP0009697_abnormal_copulation | 1.45406059 |
29 | MP0009643_abnormal_urine_homeostasis | 1.42429474 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.38090471 |
31 | MP0010155_abnormal_intestine_physiology | 1.37881311 |
32 | MP0003300_gastrointestinal_ulcer | 1.37342397 |
33 | MP0009785_altered_susceptibility_to | 1.35549766 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.28489693 |
35 | MP0000598_abnormal_liver_morphology | 1.26251967 |
36 | MP0003011_delayed_dark_adaptation | 1.24943956 |
37 | MP0005025_abnormal_response_to | 1.24161441 |
38 | MP0003705_abnormal_hypodermis_morpholog | 1.17448080 |
39 | MP0008260_abnormal_autophagy | 1.15996238 |
40 | MP0000858_altered_metastatic_potential | 1.14721619 |
41 | MP0005647_abnormal_sex_gland | 1.13412091 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.08302638 |
43 | MP0002419_abnormal_innate_immunity | 1.07458932 |
44 | MP0001835_abnormal_antigen_presentation | 1.07249012 |
45 | MP0009763_increased_sensitivity_to | 1.03548240 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.02652529 |
47 | MP0009764_decreased_sensitivity_to | 1.01381327 |
48 | MP0000685_abnormal_immune_system | 1.00570790 |
49 | MP0002254_reproductive_system_inflammat | 0.97948617 |
50 | MP0005408_hypopigmentation | 0.96772585 |
51 | MP0008469_abnormal_protein_level | 0.96526237 |
52 | MP0000604_amyloidosis | 0.93077422 |
53 | MP0001790_abnormal_immune_system | 0.92317819 |
54 | MP0005387_immune_system_phenotype | 0.92317819 |
55 | MP0005084_abnormal_gallbladder_morpholo | 0.91881071 |
56 | MP0005000_abnormal_immune_tolerance | 0.91797188 |
57 | MP0002148_abnormal_hypersensitivity_rea | 0.91279450 |
58 | MP0005670_abnormal_white_adipose | 0.89540699 |
59 | MP0005076_abnormal_cell_differentiation | 0.88375175 |
60 | MP0009642_abnormal_blood_homeostasis | 0.88294759 |
61 | MP0005220_abnormal_exocrine_pancreas | 0.88083784 |
62 | MP0001800_abnormal_humoral_immune | 0.85062512 |
63 | MP0004947_skin_inflammation | 0.85003215 |
64 | MP0005376_homeostasis/metabolism_phenot | 0.84225517 |
65 | MP0000490_abnormal_crypts_of | 0.84009380 |
66 | MP0009765_abnormal_xenobiotic_induced | 0.80971551 |
67 | MP0004185_abnormal_adipocyte_glucose | 0.80925719 |
68 | MP0003693_abnormal_embryo_hatching | 0.79921167 |
69 | MP0000678_abnormal_parathyroid_gland | 0.78069760 |
70 | MP0001873_stomach_inflammation | 0.77869278 |
71 | MP0002078_abnormal_glucose_homeostasis | 0.77304204 |
72 | MP0005266_abnormal_metabolism | 0.77293428 |
73 | MP0002166_altered_tumor_susceptibility | 0.76765274 |
74 | MP0005671_abnormal_response_to | 0.76578759 |
75 | MP0002876_abnormal_thyroid_physiology | 0.76356949 |
76 | MP0002452_abnormal_antigen_presenting | 0.74533110 |
77 | MP0002089_abnormal_postnatal_growth/wei | 0.74528122 |
78 | MP0003866_abnormal_defecation | 0.74137264 |
79 | MP0002723_abnormal_immune_serum | 0.73988185 |
80 | MP0005501_abnormal_skin_physiology | 0.73354701 |
81 | MP0002971_abnormal_brown_adipose | 0.73181898 |
82 | MP0005409_darkened_coat_color | 0.72221501 |
83 | MP0001533_abnormal_skeleton_physiology | 0.71447549 |
84 | MP0001915_intracranial_hemorrhage | 0.69800968 |
85 | MP0001756_abnormal_urination | 0.69580950 |
86 | MP0003718_maternal_effect | 0.68911236 |
87 | MP0006035_abnormal_mitochondrial_morpho | 0.68316239 |
88 | MP0002877_abnormal_melanocyte_morpholog | 0.66281112 |
89 | MP0001545_abnormal_hematopoietic_system | 0.66268482 |
90 | MP0005397_hematopoietic_system_phenotyp | 0.66268482 |
91 | MP0005334_abnormal_fat_pad | 0.66047314 |
92 | MP0010368_abnormal_lymphatic_system | 0.65975245 |
93 | MP0000477_abnormal_intestine_morphology | 0.65530406 |
94 | MP0004233_abnormal_muscle_weight | 0.64617084 |
95 | MP0001661_extended_life_span | 0.63941092 |
96 | MP0002998_abnormal_bone_remodeling | 0.63670936 |
97 | MP0001730_embryonic_growth_arrest | 0.63243556 |
98 | MP0005464_abnormal_platelet_physiology | 0.62201523 |
99 | MP0005535_abnormal_body_temperature | 0.61564062 |
100 | MP0002136_abnormal_kidney_physiology | 0.61103979 |
101 | MP0009053_abnormal_anal_canal | 0.60064289 |
102 | MP0003436_decreased_susceptibility_to | 0.59689790 |
103 | MP0004130_abnormal_muscle_cell | 0.57195088 |
104 | MP0005395_other_phenotype | 0.55772165 |
105 | MP0004782_abnormal_surfactant_physiolog | 0.52469630 |
106 | MP0002928_abnormal_bile_duct | 0.52405708 |
107 | MP0000639_abnormal_adrenal_gland | 0.51836718 |
108 | MP0005448_abnormal_energy_balance | 0.51366221 |
109 | MP0004264_abnormal_extraembryonic_tissu | 0.50144527 |
110 | MP0008873_increased_physiological_sensi | 0.48954077 |
111 | MP0003638_abnormal_response/metabolism_ | 0.48907189 |
112 | MP0003724_increased_susceptibility_to | 0.48843171 |
113 | MP0005666_abnormal_adipose_tissue | 0.47451955 |
114 | MP0009672_abnormal_birth_weight | 0.43633346 |
115 | MP0001853_heart_inflammation | 0.41950718 |
116 | MP0001845_abnormal_inflammatory_respons | 0.41683122 |
117 | MP0003329_amyloid_beta_deposits | 0.41310063 |
118 | MP0002970_abnormal_white_adipose | 0.40826134 |
119 | MP0003953_abnormal_hormone_level | 0.39818767 |
120 | MP0009115_abnormal_fat_cell | 0.39537627 |
121 | MP0005058_abnormal_lysosome_morphology | 0.38347095 |
122 | MP0006082_CNS_inflammation | 0.35414265 |
123 | MP0005166_decreased_susceptibility_to | 0.34156136 |
124 | MP0003690_abnormal_glial_cell | 0.33508196 |
125 | MP0010234_abnormal_vibrissa_follicle | 0.33258483 |
126 | MP0004043_abnormal_pH_regulation | 0.32914589 |
127 | MP0002796_impaired_skin_barrier | 0.32227391 |
128 | MP0003075_altered_response_to | 0.32196385 |
129 | MP0002132_abnormal_respiratory_system | 0.31933437 |
130 | MP0008874_decreased_physiological_sensi | 0.31866115 |
131 | MP0002135_abnormal_kidney_morphology | 0.31481786 |
132 | MP0008872_abnormal_physiological_respon | 0.30817203 |
133 | MP0001765_abnormal_ion_homeostasis | 0.30664146 |
134 | MP0004381_abnormal_hair_follicle | 0.29794602 |
135 | MP0001881_abnormal_mammary_gland | 0.29031181 |
136 | MP0001243_abnormal_dermal_layer | 0.28250219 |
137 | MP0002168_other_aberrant_phenotype | 0.27662916 |
138 | MP0000249_abnormal_blood_vessel | 0.26603986 |
139 | MP0005075_abnormal_melanosome_morpholog | 0.26340516 |
140 | MP0003453_abnormal_keratinocyte_physiol | 0.24729816 |
141 | MP0003699_abnormal_female_reproductive | 0.24196758 |
142 | MP0005023_abnormal_wound_healing | 0.24031821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.18027473 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.06344831 |
3 | Deep venous thrombosis (HP:0002625) | 6.80627960 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58776243 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.26625419 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.04681197 |
7 | Xanthomatosis (HP:0000991) | 6.02823468 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.09864309 |
9 | Complement deficiency (HP:0004431) | 5.00277199 |
10 | Hyperammonemia (HP:0001987) | 4.73465697 |
11 | Hypolipoproteinemia (HP:0010981) | 4.62663453 |
12 | Joint hemorrhage (HP:0005261) | 4.52229617 |
13 | Hyperglycinemia (HP:0002154) | 4.51591775 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.42699474 |
15 | Ketosis (HP:0001946) | 4.34609658 |
16 | Hyperglycinuria (HP:0003108) | 4.32420332 |
17 | Epidermoid cyst (HP:0200040) | 4.31448483 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29867594 |
19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22273597 |
20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21394645 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20454641 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.20323924 |
23 | Abnormality of glycine metabolism (HP:0010895) | 4.14568622 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.14568622 |
25 | Fat malabsorption (HP:0002630) | 4.11176408 |
26 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.09244119 |
27 | Hypoglycemic coma (HP:0001325) | 3.98783798 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.93988181 |
29 | Abnormality of complement system (HP:0005339) | 3.72479991 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63046025 |
31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51455430 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.49812650 |
33 | Hypercholesterolemia (HP:0003124) | 3.48031011 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44896810 |
35 | Hyperbilirubinemia (HP:0002904) | 3.35194983 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34443038 |
37 | Hemorrhage of the eye (HP:0011885) | 3.26494098 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.19257648 |
39 | Ketoacidosis (HP:0001993) | 3.16783924 |
40 | Delayed CNS myelination (HP:0002188) | 3.15926626 |
41 | Steatorrhea (HP:0002570) | 3.08622883 |
42 | Purpura (HP:0000979) | 2.99260863 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.98969791 |
44 | Abnormality of purine metabolism (HP:0004352) | 2.97042497 |
45 | Gout (HP:0001997) | 2.93982906 |
46 | Metabolic acidosis (HP:0001942) | 2.86119766 |
47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84401052 |
48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84401052 |
49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84401052 |
50 | Myocardial infarction (HP:0001658) | 2.81123175 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.81031554 |
52 | Dicarboxylic aciduria (HP:0003215) | 2.81031554 |
53 | Spontaneous abortion (HP:0005268) | 2.78729600 |
54 | Lethargy (HP:0001254) | 2.77192164 |
55 | Hypochromic microcytic anemia (HP:0004840) | 2.69049923 |
56 | Acanthocytosis (HP:0001927) | 2.62878355 |
57 | Spastic diplegia (HP:0001264) | 2.59200802 |
58 | Vascular calcification (HP:0004934) | 2.57189293 |
59 | Systemic lupus erythematosus (HP:0002725) | 2.56829682 |
60 | Skin nodule (HP:0200036) | 2.53944729 |
61 | Cerebral edema (HP:0002181) | 2.49568797 |
62 | Malnutrition (HP:0004395) | 2.47685378 |
63 | Hypoglycemic seizures (HP:0002173) | 2.46225319 |
64 | Nephritis (HP:0000123) | 2.43614166 |
65 | Irritability (HP:0000737) | 2.43431515 |
66 | Vacuolated lymphocytes (HP:0001922) | 2.43297136 |
67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42813614 |
68 | Increased serum ferritin (HP:0003281) | 2.40739984 |
69 | Generalized aminoaciduria (HP:0002909) | 2.39964195 |
70 | Neonatal onset (HP:0003623) | 2.35407036 |
71 | Late onset (HP:0003584) | 2.33648992 |
72 | Abnormal gallbladder morphology (HP:0012437) | 2.31758892 |
73 | Increased cerebral lipofuscin (HP:0011813) | 2.31418308 |
74 | Pancreatitis (HP:0001733) | 2.27819690 |
75 | Dysostosis multiplex (HP:0000943) | 2.27760943 |
76 | Cholelithiasis (HP:0001081) | 2.27556558 |
77 | Glomerulonephritis (HP:0000099) | 2.25873935 |
78 | Mucopolysacchariduria (HP:0008155) | 2.25232640 |
79 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25232640 |
80 | Abnormal gallbladder physiology (HP:0012438) | 2.24778909 |
81 | Cholecystitis (HP:0001082) | 2.24778909 |
82 | Cardiovascular calcification (HP:0011915) | 2.24274934 |
83 | Hypophosphatemia (HP:0002148) | 2.22033779 |
84 | Abnormality of the Achilles tendon (HP:0005109) | 2.19160716 |
85 | Vomiting (HP:0002013) | 2.18226650 |
86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16701058 |
87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16701058 |
88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16701058 |
89 | Esophageal varix (HP:0002040) | 2.15470146 |
90 | Elevated alkaline phosphatase (HP:0003155) | 2.15077248 |
91 | Reduced antithrombin III activity (HP:0001976) | 2.14854694 |
92 | Mitral stenosis (HP:0001718) | 2.14184582 |
93 | Proximal tubulopathy (HP:0000114) | 2.14092357 |
94 | Brushfield spots (HP:0001088) | 2.13982031 |
95 | Ragged-red muscle fibers (HP:0003200) | 2.11093849 |
96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.10373166 |
97 | Abnormal tarsal ossification (HP:0008369) | 2.10307993 |
98 | Thrombophlebitis (HP:0004418) | 2.09969486 |
99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09775528 |
100 | Sensorimotor neuropathy (HP:0007141) | 2.08333826 |
101 | Flat acetabular roof (HP:0003180) | 2.07475077 |
102 | Hyperuricemia (HP:0002149) | 2.06219129 |
103 | Increased purine levels (HP:0004368) | 2.06219129 |
104 | Gingival bleeding (HP:0000225) | 2.06139329 |
105 | Enlarged kidneys (HP:0000105) | 2.05940838 |
106 | Poikilocytosis (HP:0004447) | 2.05592759 |
107 | Menorrhagia (HP:0000132) | 2.04969269 |
108 | Opisthotonus (HP:0002179) | 2.04619336 |
109 | Abnormality of macrophages (HP:0004311) | 2.03556242 |
110 | Hydroxyprolinuria (HP:0003080) | 2.02633513 |
111 | Abnormality of proline metabolism (HP:0010907) | 2.02633513 |
112 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02420191 |
113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02026882 |
114 | Eczematoid dermatitis (HP:0000976) | 2.01476581 |
115 | Amyloidosis (HP:0011034) | 2.00943333 |
116 | Alkalosis (HP:0001948) | 2.00543118 |
117 | Abnormality of iron homeostasis (HP:0011031) | 1.98211207 |
118 | Vertebral compression fractures (HP:0002953) | 1.98186433 |
119 | Widely patent fontanelles and sutures (HP:0004492) | 1.97009815 |
120 | Abnormal cartilage morphology (HP:0002763) | 1.96988947 |
121 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95122180 |
122 | Nausea (HP:0002018) | 1.91931864 |
123 | Abnormality of the gallbladder (HP:0005264) | 1.91548537 |
124 | Elevated hepatic transaminases (HP:0002910) | 1.90822706 |
125 | Renal cortical cysts (HP:0000803) | 1.89100106 |
126 | Glycosuria (HP:0003076) | 1.89065113 |
127 | Abnormality of urine glucose concentration (HP:0011016) | 1.89065113 |
128 | Abnormality of glycolysis (HP:0004366) | 1.88396823 |
129 | Rickets (HP:0002748) | 1.87992065 |
130 | Loss of speech (HP:0002371) | 1.87625498 |
131 | Abdominal distention (HP:0003270) | 1.85692279 |
132 | Increased serum pyruvate (HP:0003542) | 1.84305916 |
133 | Bone pain (HP:0002653) | 1.78929661 |
134 | Seborrheic dermatitis (HP:0001051) | 1.76356163 |
135 | Thoracic kyphosis (HP:0002942) | 1.75543831 |
136 | Progressive neurologic deterioration (HP:0002344) | 1.74893050 |
137 | Abnormality of the lumbar spine (HP:0100712) | 1.74280319 |
138 | Thin bony cortex (HP:0002753) | 1.73675117 |
139 | J-shaped sella turcica (HP:0002680) | 1.70787289 |
140 | Joint swelling (HP:0001386) | 1.70506395 |
141 | Polycythemia (HP:0001901) | 1.67503402 |
142 | Impaired platelet aggregation (HP:0003540) | 1.67494917 |
143 | Abnormal platelet function (HP:0011869) | 1.67494917 |
144 | Pulmonary embolism (HP:0002204) | 1.67458947 |
145 | Abnormality of vitamin metabolism (HP:0100508) | 1.67322257 |
146 | Polygenic inheritance (HP:0010982) | 1.67141193 |
147 | Achilles tendon contracture (HP:0001771) | 1.66364828 |
148 | Abnormality of carpal bone ossification (HP:0006257) | 1.64497306 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.68661940 |
2 | ERN1 | 4.22886953 |
3 | FGFR4 | 3.94888864 |
4 | SIK1 | 3.71262700 |
5 | SMG1 | 3.08506621 |
6 | PRPF4B | 2.88337256 |
7 | TAOK3 | 2.84182239 |
8 | ERBB4 | 2.80650873 |
9 | PKN2 | 2.55868565 |
10 | FLT3 | 2.51558491 |
11 | ICK | 2.45171188 |
12 | CDK12 | 2.32138625 |
13 | INSRR | 2.31907555 |
14 | SCYL2 | 2.24745751 |
15 | EEF2K | 2.17135081 |
16 | MAPK11 | 1.93199155 |
17 | RIPK4 | 1.93149094 |
18 | MST1R | 1.76491201 |
19 | TRIB3 | 1.71389391 |
20 | TYK2 | 1.68234279 |
21 | FRK | 1.64744567 |
22 | GRK6 | 1.63533221 |
23 | MAP2K4 | 1.61721164 |
24 | PIK3CG | 1.56301861 |
25 | KDR | 1.52479227 |
26 | ABL2 | 1.49460602 |
27 | MAP3K10 | 1.45956946 |
28 | LATS1 | 1.44977349 |
29 | NEK9 | 1.39299918 |
30 | MAP3K1 | 1.39052516 |
31 | MAP2K3 | 1.33452216 |
32 | PIM2 | 1.33249170 |
33 | STK38L | 1.29856289 |
34 | PTK6 | 1.24573251 |
35 | PDK4 | 1.24088336 |
36 | PDK3 | 1.24088336 |
37 | MATK | 1.19374215 |
38 | JAK2 | 1.19236612 |
39 | NEK1 | 1.14763382 |
40 | MAP3K11 | 1.14250728 |
41 | TAOK1 | 1.10960957 |
42 | MAP3K13 | 1.07483703 |
43 | KSR2 | 1.06673690 |
44 | CDK6 | 1.06490867 |
45 | PINK1 | 1.04400289 |
46 | PRKAA2 | 1.03427580 |
47 | TBK1 | 1.03337572 |
48 | RPS6KB2 | 1.03111430 |
49 | ARAF | 1.02570907 |
50 | IRAK4 | 1.01524078 |
51 | TESK2 | 1.00190246 |
52 | EIF2AK3 | 0.99439800 |
53 | MAP3K14 | 0.98966028 |
54 | IRAK3 | 0.98227577 |
55 | TESK1 | 0.97938458 |
56 | MAP3K3 | 0.96697064 |
57 | CDK4 | 0.94959213 |
58 | MAPK4 | 0.93674580 |
59 | DYRK1B | 0.92758431 |
60 | PAK4 | 0.92428250 |
61 | SIK3 | 0.85793662 |
62 | EIF2AK1 | 0.82527661 |
63 | PRKG2 | 0.82445988 |
64 | BLK | 0.80341973 |
65 | CDK7 | 0.78133516 |
66 | JAK3 | 0.77654894 |
67 | LRRK2 | 0.77425744 |
68 | PIK3CA | 0.77140803 |
69 | MAP3K7 | 0.75953150 |
70 | JAK1 | 0.72436363 |
71 | MAP2K6 | 0.72191432 |
72 | PRKAA1 | 0.71101162 |
73 | CDC42BPA | 0.68080469 |
74 | CSK | 0.67395399 |
75 | ERBB2 | 0.67254619 |
76 | CSF1R | 0.66225115 |
77 | PRKCZ | 0.64826147 |
78 | DDR2 | 0.64578425 |
79 | DAPK2 | 0.63481409 |
80 | MAP3K2 | 0.63029930 |
81 | LMTK2 | 0.62016230 |
82 | MAPK15 | 0.61811456 |
83 | GSK3A | 0.60981676 |
84 | PRKACG | 0.59265836 |
85 | ACVR1B | 0.57852688 |
86 | PIM1 | 0.56017776 |
87 | MAP3K5 | 0.55850846 |
88 | MET | 0.55566284 |
89 | ALK | 0.55472553 |
90 | EPHA2 | 0.54948343 |
91 | CDK9 | 0.54500069 |
92 | MAP3K6 | 0.53863387 |
93 | FGFR2 | 0.53648728 |
94 | IKBKE | 0.53348409 |
95 | PDK2 | 0.52898785 |
96 | PDGFRA | 0.51493476 |
97 | SGK3 | 0.49022778 |
98 | TGFBR2 | 0.49007646 |
99 | IKBKB | 0.48355496 |
100 | MAP4K1 | 0.48349841 |
101 | TAOK2 | 0.47536134 |
102 | WEE1 | 0.47214955 |
103 | SIK2 | 0.46525514 |
104 | NME2 | 0.45720538 |
105 | MAPKAPK3 | 0.45217995 |
106 | WNK3 | 0.44395876 |
107 | RPS6KB1 | 0.43874050 |
108 | RET | 0.43376072 |
109 | KIT | 0.43372448 |
110 | FGR | 0.42327435 |
111 | RIPK1 | 0.42079368 |
112 | EPHB1 | 0.41643132 |
113 | AKT2 | 0.41497935 |
114 | CAMK1D | 0.41161463 |
115 | IRAK2 | 0.40619804 |
116 | MAP3K8 | 0.40345773 |
117 | ZAP70 | 0.40243396 |
118 | MAPK12 | 0.39681721 |
119 | STK4 | 0.38537544 |
120 | MAPKAPK2 | 0.37727279 |
121 | MTOR | 0.37527522 |
122 | PBK | 0.36905622 |
123 | CLK1 | 0.36409462 |
124 | BRAF | 0.36384443 |
125 | MAP2K2 | 0.35377110 |
126 | FGFR3 | 0.35246840 |
127 | PTK2 | 0.34517728 |
128 | BTK | 0.33951579 |
129 | STK10 | 0.33789179 |
130 | LYN | 0.33368591 |
131 | SGK2 | 0.33169286 |
132 | STK16 | 0.32839676 |
133 | CAMK2G | 0.32431042 |
134 | TTK | 0.30446473 |
135 | PDPK1 | 0.30319858 |
136 | RPS6KC1 | 0.29768215 |
137 | RPS6KL1 | 0.29768215 |
138 | LATS2 | 0.29328926 |
139 | STK3 | 0.29113954 |
140 | CHUK | 0.25707081 |
141 | NEK2 | 0.25454114 |
142 | TIE1 | 0.25398132 |
143 | IGF1R | 0.24782162 |
144 | CSNK1G1 | 0.24543822 |
145 | PDK1 | 0.24048570 |
146 | MAP2K1 | 0.23217187 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30750095 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44669694 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39539909 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29013676 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99545718 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73979259 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64962896 |
8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62045907 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53288300 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51619044 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51052898 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45764447 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35329695 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.11475004 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09504801 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04225096 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02514810 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86479884 |
19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85490836 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83986314 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83094866 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80546470 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79067131 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75847286 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73911336 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73698963 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70379778 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69153114 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67303764 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61713401 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61216235 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52103884 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50283280 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49953188 |
35 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49425472 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46083333 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44188264 |
38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40067156 |
39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39405005 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.38233854 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32782135 |
42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31801934 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30947436 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30615892 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29586827 |
46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29197884 |
47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21950478 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.11634955 |
49 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08938519 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08379767 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04336863 |
52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04324485 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03886946 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01640812 |
55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99107472 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97724790 |
57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91147496 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88313779 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88165920 |
60 | Lysosome_Homo sapiens_hsa04142 | 0.87615917 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87329274 |
62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83156795 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.83061616 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82449563 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76864185 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75514943 |
67 | Pertussis_Homo sapiens_hsa05133 | 0.68868024 |
68 | Mineral absorption_Homo sapiens_hsa04978 | 0.56725908 |
69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54889672 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53070917 |
71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51228014 |
72 | Allograft rejection_Homo sapiens_hsa05330 | 0.47421325 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47046871 |
74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47010523 |
75 | Asthma_Homo sapiens_hsa05310 | 0.46454613 |
76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46221109 |
77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43896436 |
78 | Influenza A_Homo sapiens_hsa05164 | 0.41450022 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40991046 |
80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40021609 |
81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38098549 |
82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38064336 |
83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34072543 |
84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34053689 |
85 | Tuberculosis_Homo sapiens_hsa05152 | 0.32358308 |
86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.31862740 |
87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29613663 |
88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29278392 |
89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26796374 |
90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26680006 |
91 | Prion diseases_Homo sapiens_hsa05020 | 0.25094769 |
92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.24522233 |
93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22122317 |
94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21246647 |
95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20420782 |
96 | Apoptosis_Homo sapiens_hsa04210 | 0.20341635 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.19234269 |
98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17329148 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13971910 |
100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09566116 |
101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09522636 |
102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08394354 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02702716 |
104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01727131 |
105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2313554 |
106 | Bladder cancer_Homo sapiens_hsa05219 | -0.2248048 |
107 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2143627 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2142641 |
109 | Legionellosis_Homo sapiens_hsa05134 | -0.2046583 |
110 | Hepatitis C_Homo sapiens_hsa05160 | -0.1935436 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1784396 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1762704 |
113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1749217 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1504030 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1294522 |
116 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1132467 |
117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1079386 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1045961 |
119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0796375 |
120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0658014 |
121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0498735 |
122 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0489433 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0303972 |